Role of mTOR-Chk1 in enhancing DNA-damaging therapy
- PMID: 25928228
- PMCID: PMC4612500
- DOI: 10.1080/15384101.2015.1046790
Role of mTOR-Chk1 in enhancing DNA-damaging therapy
Comment on
-
DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1.Oncotarget. 2015 Jan 1;6(1):427-40. doi: 10.18632/oncotarget.2813. Oncotarget. 2015. PMID: 25460505 Free PMC article.
References
-
- Laplante M, Sabatini DM. Cell 2012; 149:274-93; PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03.017 - DOI - PMC - PubMed
-
- Guo F, et al.. Leukemia 2013; 27:2040-6; PMID:23538752; http://dx.doi.org/10.1038/leu.2013.93 - DOI - PMC - PubMed
-
- Shen C, et al.. Cancer Res 2013; 73:3393-401; PMID:23633493; http://dx.doi.org/10.1158/0008-5472.CAN-12-4282; - DOI - PMC - PubMed
-
- Weisman R, et al.. EMBO Mol Med 2014; 6:995-1002; PMID:24992933; http://dx.doi.org/10.15252/emmm.201403959 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous